Skip to main content

Table 1 Patient baseline characteristics[±s, n(%)]

From: Correlation between ischemia-modified albumin level and coronary collateral circulation

Variables

Good CCC

(n = 59)

Poor CCC

(n = 69)

P

Age (years)

60.92 ± 11.61

61.28 ± 11.61

0.861

Male

45 (76.3)

45 (65.2)

0.172

Coronary heart disease

10 (16.9)

5 (7.2)

0.089

Hypertension

39 (66.1)

35 (50.7)

0.079

Diabetes mellitus

9 (15.3)

24 (34.8)

0.012

Smoking

25 (42.4)

27 (39.1)

0.710

Drinking

10 (16.9)

14 (20.3)

0.629

Statins

8 (13.6)

3 (4.3)

0.064

Aspirin

6 (10.2)

3 (4.3)

0.300

ACEI/ARB

10 (16.9)

16 (23.2)

0.382

Platelet(× 10^9/L)

195.97 ± 55.46

218.30 ± 71.62

0.049

Neutrophil(× 10^9/L)

5.45 (3.70,6.21)

6.48 (3.75,8.78)

0.091

Lymphocyte(×10^9/L)

1.64 (1.12,1.89)

1.41 (1.02,1.79)

0.105

Monocyte(×10^9/L)

0.66 (0.37,0.64)

0.56 (0.36,0.63)

0.636

Total cholesterol (mmoL/L)

4.79 (3.72,5.30)

4.43 (3.58,5.21)

0.247

Triglyceride (mmoL/L)

2.14 (1.06,2.19)

1.81 (0.99,2.22)

0.602

HDL-C (mmoL/L)

0.98 (0.82,1.11)

1.88 (0.78,1.10)

0.482

LDL-C (mmoL/L)

2.94 ± 1.06

2.80 ± 0.89

0.418

LP(a)(mg/L)

214.96 (76.30,289.10)

202.16 (56.85,244.45)

0.324

Total bilirubin (μmoL/L)

15.04 ± 5.63

12.58 ± 5.01

0.010

IMA (KU/L)

66.31 ± 5.94

60.51 ± 5.45

< 0.001

Uric acid (μmoL/L)

373.61 ± 111.65

368.76 ± 108.56

0.804

LVEF(%)

60.67 ± 10.28

62.34 ± 8.96

0.327

Occlusive vessels

 Multivessel

13 (22.0)

8 (11.6)

0.112

 LAD

25 (42.4)

23 (33.3)

0.292

 LCX

4 (6.8)

12 (17.4)

0.070

 RCA

17 (28.2)

26 (37.7)

0.290

  1. CCC:coronary collateral circulation;ACEI:angiotensin converting enzyme inhibitors;ARB:Angiotensin II receptor antagonist;HDL-C:high density lipoprotein cholesterol;LDL-C:low density lipoprotein cholesterol;LP(a):lipoprotein a;IMA:ischemic modified albumin;LVEF:left ventricular ejection fraction;Occlusive vessels:more than two main coronary arteries;LAD:left anterior descending artery;LCX:left circumflex;RCA:Right coronary artery